Efficacy of metyrapone for symptoms of adrenocortical carcinoma.

Okuda, Yuka; Kuriyama, Toshiyuki; Kawamata, Tomoyuki

Okuda, Yuka; Kuriyama, Toshiyuki; Kawamata, Tomoyuki.

Afiliação

Okuda Y; Department of Anesthesiology, Wakayama Medical University, Wakayama, Japan yuuka-o@wakayama-med.ac.jp.
Kuriyama T; Department of Anesthesiology, Wakayama Medical University, Wakayama, Japan.
Kawamata T; Department of Anesthesiology, Wakayama Medical University, Wakayama, Japan.

BMJ Support Palliat Care ; 13(e3): e971-e973, 2024 Jan 08.

Article em En | MEDLINE | ID: mdl-37130722

RESUMO

Elevated cortisol by adrenocortical carcinoma leads to a variety of symptoms. We report on the efficacy of metyrapone in treatment of a variety of distressing symptoms caused by elevated cortisol in a patient who refused advanced treatment for adrenocortical carcinoma.

Assuntos

Neoplasias do Córtex Suprarrenal; Carcinoma Adrenocortical; Humanos; Metirapona/uso terapêutico; Carcinoma Adrenocortical/complicações; Carcinoma Adrenocortical/tratamento farmacológico; Hidrocortisona/uso terapêutico; Neoplasias do Córtex Suprarrenal/complicações; Neoplasias do Córtex Suprarrenal/tratamento farmacológico

Palavras-chave

supportive care; terminal care

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: BMJ Support Palliat Care Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google